Drug
Aro Atxn2
Aro Atxn2: highest development phase Phase 1, developed by Arrowhead Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Arrowhead Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| ARO-ATXN2 Injection NCT06672445 | Phase 1 | Spinocerebellar Ataxia Type 2 |
Latest
No recent events.
Follow Aro Atxn2 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.